semaglutide litigation Trulicity Lawsuit [2026] dallas glp-1 attorney semaglutide gastric

(5) Reverse NET transport and hypertensive crisis: Increased cytoplasmic NE and transporter phosphorylation drive NET-mediated reverse transport, resulting in massive non-exocytotic NE release into the synaptic cleft and a marked rise in blood pressure

This clip starts at 0:45

The peptide is naturally occurring and well-tolerated

At the end of 2024, there were 27,656 total reports involving Ozempic: 10,418 reports of Ozempic adverse events in 2024 alone 386 total death reports in people taking Ozempic * FAERS is intended to help identify safety concerns related to marketed products, but it does not prove any product or drug is linked or caused a particular side effect or injury